ORAL ADMINISTRATION DRUG COMPRISING CLOPIDOGREL BESYLATE

摘要

The present invention relates to clopidogrel besylate, and more specifically to a pharmaceutical drug for oral administration containing clopidogrel besylate as an active ingredient, which has superior therapeutic effects from the aspects of pharmacokinetics and pharmacodynamics and storage stability while eliminating difficulty in tableting step by wet granulation method adding a binding solution containing a low-grade alcohol during its manufacturing process, and a method of its preparation.